Group One Trading’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-270
| Closed | -$338 | – | 8506 |
|
|
2023
Q3 | $338 | Hold |
270
| – | – | ﹤0.01% | 7385 |
|
|
2023
Q2 | $327 | Buy |
270
+3
| +1% | +$17 | ﹤0.01% | 7417 |
|
|
2023
Q1 | $2.72K | Buy |
267
+240
| +889% | +$3.47K | ﹤0.01% | 6530 |
|
|
2022
Q4 | $429 | Hold |
27
| – | – | ﹤0.01% | 6963 |
|
|
2022
Q3 | $1K | Sell |
27
-527
| -95% | -$15.6K | ﹤0.01% | 7424 |
|
|
2022
Q2 | $16K | Sell |
554
-6
| -1% | -$273 | ﹤0.01% | 6486 |
|
|
2022
Q1 | $39K | Sell |
560
-17
| -3% | -$1.34K | ﹤0.01% | 6305 |
|
|
2021
Q4 | $63K | Buy |
+577
| New | +$66.5K | ﹤0.01% | 6145 |
|
|
2021
Q1 | – | Sell |
-2
| Closed | -$363 | – | 8184 |
|
|
2020
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 7183 |
|
|
2020
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 6701 |
|
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 6340 |
|
|
2020
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 5923 |
|
|
2019
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5786 |
|
|
2019
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 5696 |
|
|
2019
Q2 | $1K | Hold |
2
| – | – | ﹤0.01% | 4851 |
|
|
2019
Q1 | $1K | Hold |
2
| – | – | ﹤0.01% | 4686 |
|
|
2018
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5584 |
|
|
2018
Q3 | $1K | Buy |
+2
| New | +$2.55K | ﹤0.01% | 5094 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 5078 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4632 |
|
Group One Trading's BIOC Position: Q4 2023 in Review
Group One Trading sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 270 shares — an estimated $338 sold.
Group One Trading first reported a position in BIOC in Q3 2018 and held it in 18 quarters. The position peaked at $63K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.
- Group One Trading reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 270 Biocept, Inc. shares in Q4 2023, an estimated $338.
- Group One Trading first reported a position in Biocept, Inc. in Q3 2018 and held it in 18 quarters.
- Group One Trading's Biocept, Inc. position peaked at $63K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.